Advanced glycation end products in vitreous: Structural and functional implications for diabetic vitreopathy

Investigative Ophthalmology and Visual Science

Volumn 39, Issue 13, 1998, Pages 2517-2523

  Stitt, Alan W ^a   Moore, Jonathan E ^b   Sharkey, James A ^b   Murphy, Grainne ^a   Simpson, David A C ^a   Bucala, Richard ^c   Vlassara, Helen ^c   Archer, Desmond B ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b ROYAL VICTORIA HOSPITAL   (United Kingdom)

^c PICOWER INST FOR MEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT;

ADULT; AGED; AGING; ANIMAL TISSUE; ARTICLE; CATTLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS LINKING; DIABETES MELLITUS; DIABETIC VITREOPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; NONHUMAN; PRIORITY JOURNAL; VITREOUS DISEASE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CATTLE; CHILD; CHILD, PRESCHOOL; COLLAGEN; DIABETIC RETINOPATHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE; GLYCOSYLATION END PRODUCTS, ADVANCED; GUANIDINES; HUMANS; INFANT; MALE; MICROSCOPY, IMMUNOELECTRON; MIDDLE AGED; VITRECTOMY; VITREOUS BODY;

EID: 0031736635     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Bucala R, Vlassara H, Cerami A Advanced glycosylation endproducts. In: Harding JJ, Crabbe MJC, eds. Post Translational Modifications of Proteins. Vol 2. Boca Raton, FL: CRS Press; 1992:53-59.
2. Stitt AW, Li YM, Gardiner TA, Bucala R, Archer DB, Vlassara H. Advanced glycation endproducts (AGEs) co-localise with AGE-receptors in the retinal vasculature of diabetic and AGE-infused rats. Am J Pathol. 1997;150:523-532.
3. Vlassara H, Bucala R, Striker L. Pathogenic effects of advanced glycosylation endproducts: biochemical, biologic, and clinical implications for diabetes and aging. Lab Invest. 1994;70:138-151.
4. Monnier VM, Cerami A. Non enzymatic browning in vivo: possible process for aging of long-lived proteins. Science. 1981;211:491-494.
5. Kohn RR, Cerami A, Monnier A. Collagen aging in vitro by nonenzymatic glycosylation and browning. Diabetes. 1984;33:57-59.
6. Charonis AS, Tsilibary EC. Structural and functional changes of laminin and type PV collagen after nonenzymatic glycation. Diabetes. 1992;41(Suppl 2):49-51.
7. Monnier VM, Stevens VJ, Cerami A. The browning reaction of proteins with glucose. Arch Biochem. 1979;24:157-178.
8. Scott JE. The chemical morphology of the vitreous. Eye. 1992;6: 553-555.
9. Bishop PN, Crossman MV, McLeod D, Ayad S. Extraction and characterization of the tissue forms of collagen types II and IX from bovine vitreous. Biochem J. 1994;299:497-505.
10. Balazs EA, Denlinger JL. Aging changes in the vitreous. In: Sekuler R, Kline D, Dismukes K, eds. Aging and Human Visual function. New York: Alan R. Liss; 1982:45-57.
11. Sebag J. The vitreous. In: Hart WM Jr, ed. Adlers Physiology of the Eye. 9th ed. St. Louis: Mosby; 1992:268-317.
12. Foos RY, Wheeler NC. Vitreoretinal juncture: synchysis senelis and posterior vitreous detachment. Ophthalmology. 1982;12:225-231.
13. Sebag J. Diabetic vitreopathy. Ophthalmology. 1996;103:205-206.
14. Montesano R, Kumar S, Orci L, Pepper MS. Synergistic effect of hyaluronan oligosaccharides and vascular endothelial growth factor on angiogenesis in vitro. Lab Invest. 1996;75:249-262.
15. Sebag J, Buckingham B, Charles MA, Reiser K. Biochemical abnormalities in vitreous of humans with proliferative diabetic retinopathy. Arch Ophthalmol. 1992;110:1472-1476.
16. Mitsuhashi T, Vlassara H, Founds HW, Li YM. Standardizing the immunological measurement of advanced glycation endproducts using normal human serum. J Immunol Methods. 1997;207:79-88.
17. Makita Z, Vlassara H, Cerami A, Bucala R. Immunological detection of advanced glycosylation end products in vivo. J Biol Chem. 1992;267:5133-5138.
18. Akiba J, Veno N, Chakrabarti B. Mechanisms of photo-induced vitreous liquefaction. Curr Eye Res. 1994;13:505-512.
19. Heukeshoven J, Dernick R. Simplified method for silver staining of proteins in polyacrylamide gels and the mechanism of silver staining. Electrophoresis. 1985;6:103-112.
20. Stitt AW, Chakravarthy U, Gardiner TA, Archer DB. Endothelin-like immunoreactivity and binding in the choroid, retina and optic nerve. Curr Eye Res. 1996;15:111-117.
21. Nakamura Y, Horii Y, Nishino T, et al. Immunocytochemical localization of advanced glycosylation endproducts in coronary atheroma and cardiac tissue in diabetes mellitus. Am J Pathol. 1993; 143:1649-1656
22. Lindquist O, Österlin S. Glucose concentration in the vitreous of nondiabetic and diabetic human eyes. Graefes Arch Clin Exp Ophthalmol. 1994;232:71-74.
23. Sebag J, Nie S, Reiser K, Charles A, Yu N-Y. Raman spectroscopy of human vitreous in proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci. 1994;35:2976-2980.
24. Miyata T, Taneda S, Kawai R, et al. Identification of pentosidine as a native structure for advanced glycation end products in beta-2-microglobulin-containing amyloid fibrils in patients with dialysis-related amyloidosis. Proc Natl Acad Sci USA. 1996;93:2353-2358.
25. Niwa T, Katsuzaki T, Miyazaki S, et al. Immunohistochemical detection of imidazolone, a novel advanced glycation end product, in kidneys and aortas of diabetic patients. J Clin Invest. 1997;99: 1272-1280.
26. Bruel A. Oxlund H. Changes in biomechanical properties, composition of collagen and elastin, and advanced glycation endproducts of the rat aorta in relation to age. Atherosclerosis. 1996;127:155-165.
27. Jiaan DB, Seftel AD, Fogarty J, et al. Age-related increase in an advanced glycation end product in penile tissue. World J Urol. 1995;13:369-375.
28. Munch G, Thome J, Foley P, Schinzel R, Riederer. Advanced glycation endproducts in ageing and Alzheimer's disease. Brain Res Rev. 1997;23:134-143.
29. Paul RG, Bailey AJ. Glycation of collagen: the basis of its central role in the late complications of ageing and diabetes. Int J Biochem Cell Biol. 1996;28:1297-1310.
30. Stitt AW, Vlassara H, Bucala R. Atherogenesis and advanced glycation: promotion, progression, and prevention. Ann N Y Acad Sci. 1997;811:115-129.
31. Li YM, Steffes M, Donnelly T, et al. Prevention of cardiovascular and renal pathology of aging by the advanced glycation inhibitor aminoguanidine. Proc Natl Acad Sci USA. 1996;93:3902-3907.
32. Bishop PN, Rearden AJ, McLeod D, Ayad S. Identification of alternatively spliced variants of type II procollagen in vitreous. Biochem Biophys Res Commun. 1994;203:298-295.
33. Snowden JM, Eyre DR, Swann DA. Age-related changes in the thermal stability and crosslinks of vitreous, articular cartilage and tendon collagens. Biochim Biophys Acta. 1982;706:153-157.
34. Aguayo J, Glaser B, Mildvan A, Cheng HM, Gonzalez RG, Brady T. Study of vitreous liquefaction by NMR spectroscopy and imaging. Invest Ophthalmol Vis Sci. 1985;26:692-697.
35. Sebag J. Abnormalities of human vitreous structure in diabetes. Graefes Arch Clin Exp Ophthalmol. 1987;225:89-93.
36. Wells-Knecht MC, Thorpe SR, Baynes JW. Pathways of formation of glycoxidation products during glycation of collagen. Biochemistry. 1995;34:15134-15141.
37. Fu M-X, Wells-Knecht KJ, Blackledge JA, Lyons TJ, Thorpe SR, Baynes JW. Glycation, glycoxidation, and cross-linking of collagen by glucose. Diabetes. 1994;43:676-683.
38. Chace KV, Carbelli R, Nordquist RE. The role of nonenzymatic glycosylation, transition metals, and free radicals in the formation of collagen aggregates. Arch Biochem Biophys. 1991;288:473-480.
39. Brownlee M, Vlassara H, Kooney A, Ulrich P, Cerami A. Amino-guanidine prevents diabetes-induced arterial wall protein cross-linking. Science. 1986;232:1629-1632.
40. Kakehashi A, Akiba J, Ueno N, Chakrabarti B. Evidence for singlet oxygen-induced crosslinks and aggregation of collagen. Biochem Biophys Res Commun. 1993;196:1440-1446.